Annual Shareholders Equity
-$454.99 M
-$131.22 M-40.53%
31 December 2023
Summary:
Esperion Therapeutics annual stockholders equity is currently -$454.99 million, with the most recent change of -$131.22 million (-40.53%) on 31 December 2023. During the last 3 years, it has fallen by -$358.86 million (-373.29%). ESPR annual shareholders equity is now -258.39% below its all-time high of $287.26 million, reached on 31 December 2015.ESPR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$370.21 M
-$25.99 M-7.55%
30 September 2024
Summary:
Esperion Therapeutics quarterly stockholders equity is currently -$370.21 million, with the most recent change of -$25.99 million (-7.55%) on 30 September 2024. Over the past year, it has increased by +$39.80 million (+9.71%). ESPR quarterly shareholders equity is now -217.74% below its all-time high of $314.43 million, reached on 31 March 2015.ESPR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.5% | +9.7% |
| 3 y3 years | -373.3% | -2.1% |
| 5 y5 years | -675.1% | -640.4% |
ESPR Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -373.3% | at low | -88.0% | +18.6% |
| 5 y | 5 years | -675.1% | at low | -533.0% | +18.6% |
| alltime | all time | -258.4% | at low | -217.7% | +18.6% |
Esperion Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$370.21 M(+7.6%) |
| June 2024 | - | -$344.22 M(+17.0%) |
| Mar 2024 | - | -$294.30 M(-35.3%) |
| Dec 2023 | -$454.99 M(+40.5%) | -$454.99 M(+11.0%) |
| Sept 2023 | - | -$410.00 M(+10.2%) |
| June 2023 | - | -$371.98 M(+12.8%) |
| Mar 2023 | - | -$329.66 M(+1.8%) |
| Dec 2022 | -$323.78 M(+64.4%) | -$323.78 M(+10.1%) |
| Sept 2022 | - | -$294.10 M(+0.8%) |
| June 2022 | - | -$291.70 M(+17.1%) |
| Mar 2022 | - | -$249.04 M(+26.5%) |
| Dec 2021 | -$196.94 M(+104.9%) | -$196.94 M(-45.7%) |
| Sept 2021 | - | -$362.70 M(+19.2%) |
| June 2021 | - | -$304.31 M(+13.0%) |
| Mar 2021 | - | -$269.39 M(+180.2%) |
| Dec 2020 | -$96.13 M(-581.9%) | -$96.13 M(-1172.9%) |
| Sept 2020 | - | $8.96 M(-89.5%) |
| June 2020 | - | $85.49 M(-270.1%) |
| Mar 2020 | - | -$50.25 M(-351.9%) |
| Dec 2019 | $19.95 M(-74.8%) | $19.95 M(-70.9%) |
| Sept 2019 | - | $68.51 M(-47.0%) |
| June 2019 | - | $129.33 M(-26.1%) |
| Mar 2019 | - | $175.01 M(+121.2%) |
| Dec 2018 | $79.12 M | $79.12 M(-39.9%) |
| Sept 2018 | - | $131.75 M(-25.1%) |
| June 2018 | - | $175.92 M(-17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $214.14 M(-12.5%) |
| Dec 2017 | $244.69 M(+7.0%) | $244.69 M(-12.0%) |
| Sept 2017 | - | $278.10 M(+80.5%) |
| June 2017 | - | $154.11 M(-19.9%) |
| Mar 2017 | - | $192.42 M(-15.8%) |
| Dec 2016 | $228.60 M(-20.4%) | $228.60 M(-10.1%) |
| Sept 2016 | - | $254.18 M(-5.1%) |
| June 2016 | - | $267.96 M(-3.5%) |
| Mar 2016 | - | $277.76 M(-3.3%) |
| Dec 2015 | $287.26 M(+115.1%) | $287.26 M(-3.1%) |
| Sept 2015 | - | $296.48 M(-2.9%) |
| June 2015 | - | $305.46 M(-2.9%) |
| Mar 2015 | - | $314.43 M(+135.4%) |
| Dec 2014 | $133.55 M(+80.3%) | $133.55 M(+165.9%) |
| Sept 2014 | - | $50.22 M(-14.7%) |
| June 2014 | - | $58.91 M(-12.1%) |
| Mar 2014 | - | $67.03 M(-9.5%) |
| Dec 2013 | $74.09 M(-526.1%) | $74.09 M(-11.0%) |
| Sept 2013 | - | $83.23 M(+545.7%) |
| June 2013 | - | $12.89 M(-34.7%) |
| Mar 2013 | - | $19.74 M(-213.5%) |
| Dec 2012 | -$17.39 M(+187.1%) | -$17.39 M |
| Dec 2011 | -$6.06 M(-115.6%) | - |
| Dec 2002 | $38.74 M(-41.7%) | - |
| Dec 2001 | $66.50 M(-1.8%) | - |
| Dec 2000 | $67.69 M(+2304.7%) | - |
| Dec 1999 | $2.81 M | - |
FAQ
- What is Esperion Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Esperion Therapeutics?
- What is Esperion Therapeutics annual shareholders equity year-on-year change?
- What is Esperion Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly shareholders equity year-on-year change?
What is Esperion Therapeutics annual stockholders equity?
The current annual shareholders equity of ESPR is -$454.99 M
What is the all time high annual shareholders equity for Esperion Therapeutics?
Esperion Therapeutics all-time high annual stockholders equity is $287.26 M
What is Esperion Therapeutics annual shareholders equity year-on-year change?
Over the past year, ESPR annual stockholders equity has changed by -$131.22 M (-40.53%)
What is Esperion Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ESPR is -$370.21 M
What is the all time high quarterly shareholders equity for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly stockholders equity is $314.43 M
What is Esperion Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ESPR quarterly stockholders equity has changed by +$39.80 M (+9.71%)